Echoiq Limited has released a press release.
Response to ASX Price Query
Filed with ASX ·
6ix hasn’t read this filing yet.
Earlier from EchoIQ
- Formal lodgement of FDA submission for EchoSolv HF
- Echo IQ to Present at the Life Sciences Virtual Investor Forum on 11th December
- Validation study for EchoSolv HF completed at the Mayo Clinic – Study delivers exceptional results
- Exceptional Results from Validation Study for EchoSolv HF
- Echo IQ to Participate in the Piper Sandler 37th Annual Healthcare Conference
Later from EchoIQ
- Quarterly Activities Report and Appendix 4C Cash Flow Report
- Appendix 4D 31 December 2025
- S&P DJI Announces March 2026 Quarterly Rebalance
- Update - S&P DJI March 2026 Rebalance of the All Ordinaries
- Agreement with Mayo Clinic for EchoSolv HF
Follow EchoIQ into a list and get an email when it puts out news.
Follow EchoIQ